Trial · NCT02375971
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment (Day 1 - Baseline) | STARTED | Ranibizumab 0.2 mg | 74 | |
| Treatment (Day 1 - Baseline) | STARTED | Ranibizumab 0.1 mg | 77 | |
| Treatment (Day 1 - Baseline) | STARTED | Laser Therapy | 74 | |
| Treatment (Day 1 - Baseline) | Safety Set | Ranibizumab 0.2 mg | 73 | |
| Treatment (Day 1 - Baseline) | Safety Set | Ranibizumab 0.1 mg | 76 | |
| Treatment (Day 1 - Baseline) | Safety Set | Laser Therapy | 69 | |
| Treatment (Day 1 - Baseline) | VEGF Set | Ranibizumab 0.2 mg | 19 | |
| Treatment (Day 1 - Baseline) | VEGF Set | Ranibizumab 0.1 mg | 26 | |
| Treatment (Day 1 - Baseline) | VEGF Set | Laser Therapy | 51 | |
| Treatment (Day 1 - Baseline) | PK Set | Ranibizumab 0.2 mg | 49 | |
| Treatment (Day 1 - Baseline) | PK Set | Ranibizumab 0.1 mg | 46 | |
| Treatment (Day 1 - Baseline) | PK Set | Laser Therapy | 0 | |
| Treatment (Day 1 - Baseline) | COMPLETED | Ranibizumab 0.2 mg | 73 | |
| Treatment (Day 1 - Baseline) | COMPLETED | Ranibizumab 0.1 mg | 76 | |
| Treatment (Day 1 - Baseline) | COMPLETED | Laser Therapy | 69 | |
| Treatment (Day 1 - Baseline) | NOT COMPLETED | Ranibizumab 0.2 mg | 1 | |
| Treatment (Day 1 - Baseline) | NOT COMPLETED | Ranibizumab 0.1 mg | 1 | |
| Treatment (Day 1 - Baseline) | NOT COMPLETED | Laser Therapy | 5 | |
| Follow-Up Phase (up to Day 169) | STARTED | Ranibizumab 0.2 mg | 73 | |
| Follow-Up Phase (up to Day 169) | STARTED | Ranibizumab 0.1 mg | 76 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02375971/flow